1
|
Lo Vecchio A, Scarano SM, Palladino R, Del Bene M, Trama U, Affinito G, Buono P, Guarino A. Co-administration with Men-B vaccine increases Rotavirus vaccination coverage: A 5-year regionwide retrospective cohort study (STORM study). Vaccine 2024; 42:287-294. [PMID: 38072758 DOI: 10.1016/j.vaccine.2023.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 11/24/2023] [Accepted: 12/01/2023] [Indexed: 01/01/2024]
Abstract
INTRODUCTION In Italy Rotavirus vaccination (RVV) is provided free of charge from 2018, however, the coverage is scattered and suboptimal. The narrow time frame to complete the schedule is a barrier to uptake, and co-administration with other vaccines may potentially increase the coverage. Although the co-administration of RV vaccine and Meningococcal Group B vaccine (MenB) is not included in the product labels, we aimed at studying its impact on RVV coverage. METHODS This Surveillance study on Timing and cOverage of Rotavirus and MenB vaccine co-administration (STORM study) used the Regional Vaccination Registry to collect data about children born in Campania Region between January 2016 and December 2020, and receiving vaccines scheduled in the first year of life. RESULTS Among the 224,110 children enrolled, 60,614 (27.0%) completed the RVV schedule, with a vaccination rate that increased over time from 1.15% in 2016 to 56.92% in 2020. The first and last dose of RVV schedule were administered beyond the recommended time in 6% of the study population, respectively. Co-administration of RV vaccine with MenB vaccine increased from 0.7 % in 2016 to 46.85 % in 2020. Children receiving RV/MenB vaccines concomitantly had a significantly higher chance of completing the RV schedule compared to those receiving RVV alone during a specific appointment (94.78 % vs 72.26 %, Prevalence Ratio -PR- 1.275, 95 %CI 1.245-1.295p < 0.00001). The positive driving effect of RV/MenB co-administration was more evident for children receiving pentavalent (PR 1.288) than monovalent RVV (PR 1.115) which was confirmed when adjusted for confounding variables (i.e., year of vaccination, local district, gender). CONCLUSIONS Although still far from the target, RVV coverage has increased in recent years in Campania Region. Co-administration with MenB vaccine may aid in increasing RVV coverage, especially for pentavalent RVV. Further safety data are needed to support co-administration as a key tool to increase coverage.
Collapse
Affiliation(s)
- Andrea Lo Vecchio
- Department of Translational Medical Sciences - Section of Pediatrics, University of Naples Federico II, Naples, Italy.
| | - Sara Maria Scarano
- Department of Translational Medical Sciences - Section of Pediatrics, University of Naples Federico II, Naples, Italy
| | - Raffaele Palladino
- Department of Public Health, University of Naples Federico II, Naples, Italy
| | - Margherita Del Bene
- Department of Translational Medical Sciences - Section of Pediatrics, University of Naples Federico II, Naples, Italy
| | - Ugo Trama
- Drug Policy and Devices Unit, Regione Campania Health Department, Naples, Italy
| | - Giuseppina Affinito
- Department of Public Health, University of Naples Federico II, Naples, Italy
| | - Pietro Buono
- Department of Maternal and Child Health, General Directorate for Health, Naples, Italy
| | - Alfredo Guarino
- Department of Translational Medical Sciences - Section of Pediatrics, University of Naples Federico II, Naples, Italy
| |
Collapse
|
2
|
Martinón-Torres F, de Miguel ÁG, Ruiz-Contreras J, Vallejo-Aparicio LA, García A, Gonzalez-Inchausti MC, de Gomensoro E, Kocaata Z, Gabás-Rivera C, Comellas M, Prades M, Lizán L. Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain. Infect Dis Ther 2023; 12:157-175. [PMID: 36367677 PMCID: PMC9868201 DOI: 10.1007/s40121-022-00708-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2022] [Accepted: 09/27/2022] [Indexed: 11/13/2022] Open
Abstract
INTRODUCTION Immunization is the most effective strategy for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB); however, parents need to weigh the risk-benefit and financial impact of immunizing their children against MenB in the absence of a national immunization program (NIP). This study aimed to explore societal preferences (of parents and pediatricians) regarding the attributes of a MenB vaccine in Spain. METHODS A discrete choice experiment (DCE) based on cross-sectional surveys was carried out to determine preferences. A literature review and scientific committee determined the six attributes related to the MenB vaccine included in the DCE: vaccination age, cost, duration, percentage of protection, adverse events probability, and expert/authority recommendation. Data were analyzed using a mixed logit model. Relative importance (RI) of attributes was calculated and compared between parents and pediatricians. RESULTS A total of 278 parents [55.8% female, mean age 40.4 (standard deviation, SD 7.3) years] and 200 pediatricians [73.0% female, mean age 45.8 (SD 12.9) years] answered the DCE. For parents, the highest RI was attributed to vaccine cost, expert/authority recommendation, and percentage of protection (26.4%, 26.1%, and 22.9%, respectively), while for pediatricians the highest RI was assigned to percentage of protection, expert/authority recommendation, and vaccination age (27.2%, 23.7%, and 22.6%, respectively). Significant differences between parents and pediatricians were found in the RI assigned to all attributes (p < 0.001), except for vaccine recommendation. CONCLUSION In the decision regarding MenB vaccination, cost was a driver in parental decision-making but had a low RI for pediatricians and, conversely, vaccination age was highly valued by pediatricians but was the attribute with least importance for parents. Despite these differences, expert/authority recommendation and percentage of protection were essential criteria for both groups. These results provide relevant information about MenB vaccination, highlighting the importance of considering societal preferences for NIP inclusion.
Collapse
Affiliation(s)
- Federico Martinón-Torres
- grid.411048.80000 0000 8816 6945Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain ,grid.11794.3a0000000109410645Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, University of Santiago de Compostela, Santiago de Compostela, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
| | - Ángel Gil de Miguel
- grid.28479.300000 0001 2206 5938Department of Preventive Medicine and Public Health, Universidad Rey Juan Carlos, Madrid, Spain
| | - Jesús Ruiz-Contreras
- grid.144756.50000 0001 1945 5329Department of Pediatrics, Hospital Universitario 12 de Octubre, Madrid, Spain ,grid.4795.f0000 0001 2157 7667Department of Pediatrics, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | | | | | | | | | - Zeki Kocaata
- grid.425090.a0000 0004 0468 9597GSK, Wavre, Belgium
| | | | | | | | - Luis Lizán
- Outcomes’10, Castellón, Spain ,Department of Medicine, Universidad Jaime I, Castellón, Spain
| |
Collapse
|
3
|
D'Avino A, Aloi G, Argo G, Bozza L, Canale P, Carlomagno F, Carpino A, Castaldo E, Castiglione O, Chianese P, Cioffi L, Coppola G, Costigliola C, D'Onofrio A, de Franchis R, De Giovanni M, De Magistris T, De Prosperis A, Ercolini P, Esposito A, Federico A, Gasparini N, Granata M, Iasevoli S, Losco R, Maiello R, Russo S, Sassi R, Vascone A, Vallefuoco G. Family Pediatrician and Public Health collaboration, an alliance to increase vaccination coverage: an experience with MenB vaccination in Italy. Ann Ig 2022; 34:415-420. [PMID: 34882165 DOI: 10.7416/ai.2021.2490] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
BACKGROUND Invasive Meningococcal Disease is a severe disease mainly affecting infants and young children. Most infections are caused by serogroups A, B, C, W, X, and Y. In the last 10 years, serogroup B has been the main cause of Invasive Meningococcal Disease in Europe. Recent data resulting from an observational study conducted in Italy show a significant reduction in the number of Invasive Meningococcal Disease cases due to Neisseria meningitidis B after the introduction of vaccine 4CMenB. Thus, the Naples Team of Federation of Italian Primary Care Pediatricians and the Public Health Department started an active collaboration focused on vaccination process management (named "Progetto Via") with the aim of increasing Meningococcal B vaccination coverage. STUDY DESIGN Source of data is the regional platform "GE.VA.". Every Primary care Pediatrician uses daily to record vaccination activity. This platform is integrated with data entered by operators of the District/Vaccination Center. METHODS Time: January 2019 - December 2019. The Federation of Italian Primary Care Pediatricians/Naples organized a meeting to identify six coordinators. The pediatricians could choose to counsel in their own offices and send children to the vaccination center or to counsel and vaccinate directly in their own clinics. RESULTS A total of 78 pediatricians took part in the project: 46 did only counseling and 32 did both counseling and vaccination in their medical clinic. Data obtained show an overall average vaccination coverage growth of about 13% in the first 4 months of the survey, and a further growth of about 11% in the following seven months, with a total growth in the entire period of 24%. The pediatricians' counseling is essential to recover non-compliant subjects, considering both the relationship of trust with the families and the visits already scheduled as an ideal moment for vaccinations' status check. CONCLUSIONS The project highlights how an effective collaboration between family pediatricians and the Local Health Authority becomes valuable in getting closer to reach the Ministerial goal of 95%. Vaccination coverage increased significantly when family pediatricians supported the activity of vaccine centers in distress in many regional situations. The trust relationship, the hourly availability and the capillary network of family pediatricians' clinics were key elements for the success of this project and were also recognized by parents.
Collapse
Affiliation(s)
- A D'Avino
- Italian Federation of Primary Care Pediatricians (FIMP), National Vice President, Provincial Secretary of Naples, Naples, Italy
| | - G Aloi
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - G Argo
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - L Bozza
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - P Canale
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - F Carlomagno
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - A Carpino
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - E Castaldo
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - O Castiglione
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - P Chianese
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - L Cioffi
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - G Coppola
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - C Costigliola
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - A D'Onofrio
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - R de Franchis
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - M De Giovanni
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - T De Magistris
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - A De Prosperis
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - P Ercolini
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - A Esposito
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - A Federico
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - N Gasparini
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - M Granata
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - S Iasevoli
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - R Losco
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - R Maiello
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - S Russo
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - R Sassi
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - A Vascone
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| | - G Vallefuoco
- Italian Federation of Primary Care Pediatricians (FIMP), Italy
| |
Collapse
|
4
|
Jacquinet S, Mattheus W, Quoilin S, Wyndham-Thomas C, Martin C, Van der Linden D, Mulder A, Frère J, Schirvel C. Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B in a nursery school, Wallonia, Belgium, 2018. Euro Surveill 2022; 27. [PMID: 35241214 PMCID: PMC8895469 DOI: 10.2807/1560-7917.es.2022.27.9.2100224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Abstract
Although most invasive meningococcal disease (IMD) cases are sporadic without identified transmission links, outbreaks can occur. We report three cases caused by meningococcus B (MenB) at a Belgian nursery school over 9 months. The first two cases of IMD occurred in spring and summer 2018 in healthy children (aged 3–5 years) attending the same classroom. Chemoprophylaxis was given to close contacts of both cases following regional guidelines. The third case, a healthy child of similar age in the same class as a sibling of one case, developed disease in late 2018. Microbiological analyses revealed MenB with identical finetype clonal complex 269 for Case 1 and 3 (unavailable for Case 2). Antimicrobial susceptibility testing revealed no antibiotic resistance. Following Case 3, after multidisciplinary discussion, chemoprophylaxis and 4CMenB (Bexsero) vaccination were offered to close contacts. In the 12-month follow-up of Case 3, no additional cases were reported by the school. IMD outbreaks are difficult to manage and generate public anxiety, particularly in the case of an ongoing cluster, despite contact tracing and management. This outbreak resulted in the addition of MenB vaccination to close contacts in Wallonian regional guidelines, highlighting the potential need and added value of vaccination in outbreak management.
Collapse
Affiliation(s)
- Stéphanie Jacquinet
- Epidemiology of infectious diseases, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium
| | - Wesley Mattheus
- National Reference Centre for Neisseria meningitidis, Sciensano, Brussels, Belgium
| | - Sophie Quoilin
- Epidemiology of infectious diseases, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium
| | - Chloé Wyndham-Thomas
- Epidemiology of infectious diseases, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium
| | - Charlotte Martin
- Infectious Diseases Department, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - Dimitri Van der Linden
- Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium.,Pediatric Infectious Diseases, General Pediatrics, Pediatric Department Cliniques universitaires Saint-Luc, Brussels, Belgium
| | - André Mulder
- Pediatric Intensive Care Unit, Centre Hospitalier Chrétien (CHC) Liège, Belgium
| | - Julie Frère
- University Department of Paediatrics, Centre Hospitalier Universitaire (CHU) Liège, Belgium
| | - Carole Schirvel
- Agence pour une vie de qualité, infection prevention and control, Wallonia, Belgium
| |
Collapse
|